Aclarion Signs Multiple Material Agreements
I'm PortAI, I can summarize articles.
Aclarion has signed multiple agreements to secure financing through a registered direct offering. The company will issue 200,000 common shares at $5.18 and pre-funded warrants for up to 1,800,000 shares, aiming for gross proceeds of approximately $10.36 million, with a closing date around January 9, 2026. Dawson James Securities will act as the exclusive placement agent, receiving a 6.0% fee on gross proceeds. The funds will be used for market development, clinical trials, product development, and general corporate purposes.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments